O67854 (O67854_AQUAE) Aquifex aeolicus (strain VF5)

Na(+):neurotransmitter symporter (Snf family) UniProtKBAFDB90v4InterProSTRINGInteractive Modelling

513 aa; Sequence (Fasta)

Available Structures

65 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal Structure of LeuT in the outward-open conformation in complex with Fab Heteromer
5-507
NA;SOG;
Assess
Crystal Structure of LeuT in the inward-open conformation in complex with Fab Heteromer
11-511
SOG;
Assess
Crystal structure of LeuT bound to L-leucine (30 mM) and sodiumhomo-2-mer5-513
LEU; 14×BOG;NA;
Assess
Crystal structure of LeuT bound to L-alanine and sodiumhomo-2-mer5-513
12×BOG;NA;ALA;
Assess
Crystal Structure of LeuT bound to L-selenomethionine and sodiumhomo-2-mer5-513
MSE; 10×BOG;NA;
Assess
Crystal structure of LeuT bound to 4-Fluoro-L-Phenylalanine and sodiumhomo-2-mer5-513
PFF; 10×BOG;NA;
Assess
Crystal structure of LeuT bound to glycine and sodiumhomo-2-mer5-513
GLY;BOG;NA;
Assess
Crystal structure of LeuT bound to L-Methionine and sodiumhomo-2-mer5-513
10×BOG;NA;MET;
Assess
Crystal Structure of LeuT bound to L-Tryptophan and Sodiumhomo-2-mer5-511
TRP; 14×BOG;C14;NA;
Assess
I204R1 mutant of LeuThomo-2-mer4-510
BOG;LEU;MTN;NA;CL;
Assess
F177R1 mutant of LeuThomo-2-mer5-511
12×BOG;LEU;MTN;CL;NA;
Assess
Crystal Structure of the E290S mutant of LeuT with bound OGhomo-2-mer3-506
NA;LEU;BOG;
Assess
Mechanism of substrate release in neurotransmitter:sodium symporters: the structure of LeuT in an i…homo-2-mer13-510
PHE;NA;
Assess
Crystal Structure Analysis of LeuT complexed with L-leucine, sodium, and clomipraminemonomer3-513
BOG;NA;LEU;CXX;
Assess
Crystal Structure Analysis of LeuT complexed with L-leucine, sodium, and imipraminemonomer4-513
BOG;NA;LEU;IXX;
Assess
Crystal structure analysis of LeuT complexed with L-alanine, sodium, and clomipraminemonomer4-513
BOG;NA;ALA;CXX;
Assess
Crystal structure of LEUTAA, a bacterial homolog of Na+/Cl--dependent neurotransmitter transportersmonomer5-513
BOG;NA;CL;LEU;
Assess
Crystal Structure Analysis of LeuT complexed with L-leucine, sodium and desipraminemonomer5-513
BOG;NA;LEU;DSM;
Assess
Crystal Structure of LeuT with bound OGmonomer5-513
NA;CL;LEU;BOG;
Assess
Crystal structure of LeuT in heptyl-beta-D-Selenoglucosidemonomer5-513
NA;CL;LEU;05L;
Assess
Leucine transporter LeuT in complex with sertralinemonomer5-513
LEU;NA;SRE;
Assess
LeuT in the outward-oriented, Na+-free return state, P21 form at pH 6.5monomer4-512
BOG;
Assess
Crystal structure of LeuT mutant I359Q bound to sodium and L-tryptophanmonomer5-513
TRP;NA;BOG;
Assess
Crystal structure of LeuT mutant F259V,I359Q bound to sodium and L-tryptophanmonomer5-513
TRP;NA;BOG;
Assess
Crystal Structure of an NSS Homolog with Bound Antidepressantmonomer5-513
BOG;NA;CL;LEU;DSM;
Assess
Crystal structure of T355V, S354A, K288A LeuT mutant in complex with alanine and sodiummonomer5-513
NA;ALA;
Assess
Crystal structure of LeuT-E290S with bound Brmonomer4-512
LEU;NA;BR;BOG;
Assess
Crystal structure of LeuT bound to L-leucine in space group P2 from lipid bicellesmonomer5-513
NA;LEU;
Assess
Crystal structure of LeuT-E290S with bound Clmonomer5-513
LEU;NA;CL;BOG;
Assess
Crystal structure of LeuT soaked with Crown-5monomer5-513
NA;CL;LEU;
Assess
Multicrystal structure of Na+, leucine-bound LeuT determined at 5 keVmonomer5-513
NA;CL;LEU;BOG;
Assess
Crystal structure of the R375A mutant of LeuTmonomer5-511
ALA;NA;BOG;
Assess
Crystal structure of LeuT bound to L-Alaninemonomer5-511
ALA;NA;BOG;
Assess
Crystal structure of LeuBAT (delta6 mutant) in complex with sertralinemonomer5-511
NA;SRE;BOG;
Assess
Crystal structure of LeuBAT (delta6 mutant) in complex with desvenlafaxinemonomer5-511
NA;29J;BOG;
Assess
Crystal structure of LeuBAT (delta6 mutant) in complex with (S)-duloxetinemonomer5-511
NA;29E;BOG;
Assess
Crystal structure of LeuBAT (delta6 mutant) in complex with mazindolmonomer5-511
NA;29Q;BOG;
Assess
Crystal structure of LeuT mutant F259V bound to sodium and L-tryptophanmonomer5-511
TRP;BOG;NA;
Assess
Crystal structure of LeuBAT (delta5 mutant) in complex with mazindolmonomer5-511
NA;29Q;BOG;
Assess
Crystal structure of LeuBAT (delta13 mutant) in complex with desvenlafaxinemonomer5-511
NA;29J;
Assess
Crystal structure of LeuBAT (delta13 mutant) in complex with paroxetinemonomer5-511
NA;8PR;
Assess
Crystal structure of LeuBAT (delta13 mutant) in complex with fluvoxaminemonomer5-511
NA;FVX;
Assess
Crystal structure of LeuBAT (delta13 mutant) in complex with (S)-duloxetinemonomer5-511
NA;29E;
Assess
Crystal structure of LeuBAT (delta13 mutant) in complex with sertralinemonomer5-511
NA;SRE;
Assess
Crystal structure of LeuBAT (delta13 mutant) in complex with clomipraminemonomer5-511
NA;CXX;
Assess
Crystal structure of LeuBAT (delta13 mutant) in complex with (R)-fluoxetinemonomer5-511
NA;RFX;
Assess
Leucine transporter LeuT in complex with R-fluoxetinemonomer5-510
LEU;NA;RFX;
Assess
Leucine transporter LeuT in complex with S-fluoxetinemonomer5-510
NA;LEU;SFX;
Assess
Crystal structure of LeuT bound to L-leucine in space group C2 from lipid bicellesmonomer5-509
LEU;NA;ACT;PEG;UND;PC;
Assess
Crystal structure of LeuT-F253A bound to L-leucine from lipid bicellesmonomer5-509
LEU;NA;ACT;UND;
Assess
X-ray structure of LeuT with V269 deletionmonomer4-508
LEU;NA;GOL;PEG;TRS;BOG;OCT;
Assess
Crystal Structure of LeuT bound to L-selenomethionine in space group C2 from lipid bicellesmonomer5-509
NA;MSE;ACT;PC;IOD;
Assess
Crystal structure of LeuT-F253A bound to L-selenomethionine from lipid bicellesmonomer5-509
NA;MSE;
Assess
Crystal Structure of LeuT bound to L-selenomethionine in space group C2 from lipid bicelles (collec…monomer5-509
NA;MSE;PC;IOD;
Assess
LeuT Na+-free Return State, C2 form at pH 5monomer4-508
BOG;
Assess
Crystal structure of LeuT bound to L-leucine in space group P21 from lipid bicellesmonomer5-509
LEU;NA;
Assess
Crystal structure of LeuT bound to L-selenomethionine in space group P21212 from lipid bicellesmonomer5-509
NA;MSE;
Assess
Crystal structure of LeuT bound to L-leucine in space group P21 from lipid bicellesmonomer5-509
LEU;NA;
Assess
Crystal structure of the G26C/E290S mutant of LeuTmonomer5-508
LEU;NA;BOG;
Assess
LeuT T354H mutant in the outward-oriented, Na+-free Return Statemonomer4-507
BOG;
Assess
Crystal structure of the G26C/Q250A mutant of LeuTmonomer5-508
LEU;NA;BOG;
Assess
Crystal structure of the R375D mutant of LeuTmonomer5-507
NA;ALA;BOG;
Assess
Crystal structure of LeuT in lipidic cubic phase at pH 5monomer5-507
MSE;NA;
Assess
Crystal structure of the G26C mutant of LeuTmonomer5-507
LEU;NA;
Assess
Crystal structure of LeuT in lipidic cubic phase at pH 7monomer5-506
LEU;NA;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3gwu.1.Amonomer0.845-513
LEU;SRE;100.00
Assess